Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety, Tolerability, and Efficacy of Cariprazine in Patients With Bipolar Depression

This study has been completed.
Gedeon Richter Ltd.
Information provided by (Responsible Party):
Forest Laboratories Identifier:
First received: July 15, 2011
Last updated: February 27, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 27, 2015